Product Information
KENALOG-80 80 MG/ML VIAL is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $17.8667 per ML under NDC 00003031505. Its NADAC has been published 120 times since Jun 19, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/mL
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003031505
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR; INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
New Drug (NDA)
FDA Application
NDA014901FDA Approved
Before 1982
TE Code
AB
On Market Since
4/12/2019
Pharmacological Classes
Price Statistics
The NADAC for KENALOG-80 80 MG/ML VIAL has been published 120 times since Jun 19, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.8667 per ML |
|---|---|
| All-time high | $18.0617 (Sep 11, 2024) |
| All-time low | $17.8269 (Apr 22, 2026) |
| 52-week high | $17.8844 |
| 52-week low | $17.8269 |
| Median price | $17.9181 |
| Average price | $17.9523 |
| Largest weekly change | -0.7% (Jun 18, 2025) |
| Weeks tracked | 120 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TRIAMCINOLONE ACETONIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E.R. Squibb & Sons, L.L.C. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TRIAMCINOLONE ACETONIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KENALOG-80 80 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KENALOG-80 80 MG/ML VIAL, manufactured by E.R. Squibb & Sons, L.L.C., is $17.8667 per ML (NDC 00003031505), effective Sep 30, 2026.
How has the price of KENALOG-80 80 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for KENALOG-80 80 MG/ML VIAL has held within roughly two percent of its current level. It has been tracked across 120 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for KENALOG-80 80 MG/ML VIAL?
Since Jun 19, 2024, the NADAC for KENALOG-80 80 MG/ML VIAL has ranged from a low of $17.8269 (Apr 22, 2026) to a high of $18.0617 (Sep 11, 2024), with a median of $17.9181 per ML.
Are there cheaper alternatives to KENALOG-80 80 MG/ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of KENALOG-80 80 MG/ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KENALOG-80 80 MG/ML VIAL?
KENALOG-80 80 MG/ML VIAL (NDC 00003031505) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.